International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(8), P. 7445 - 7445
Published: April 18, 2023
In
addition
to
the
acute
symptoms
after
infection,
patients
and
society
are
also
being
challenged
by
long-term
effects
of
COVID-19,
known
as
long
COVID.
Oxidative
stress,
a
pivotal
point
in
pathophysiology
could
potentially
be
involved
development
post-COVID
syndrome.
The
aim
present
study
was
evaluate
relationship
between
changes
oxidative
status
persistence
long-COVID
workers
with
previous
mild
COVID-19
infection.
A
cross-sectional
conducted
among
127
employees
an
Italian
university
(80
47
healthy
subjects).
TBARS
assay
used
detect
malondialdehyde
serum
levels
(MDA),
while
total
hydroperoxide
(TH)
production
measured
d-ROMs
kit.
significant
difference
mean
MDA
values
found
previously
infected
subjects
controls
(4.9
µm
vs.
2.8
µm,
respectively).
Receiver–operating
characteristic
(ROC)
curves
showed
high
specificity
good
sensibility
(78.7%
67.5%,
respectively)
for
levels.
random
forest
classifier
identified
hematocrit
value,
levels,
IgG
titer
against
SARS-CoV-2
features
highest
predictive
value
distinguishing
34
from
46
asymptomatic
subjects.
damage
persists
suggesting
possible
role
stress
mediators
pathogenesis
Journal of Translational Medicine,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: June 8, 2023
Post-COVID-19
syndrome
(PCS)
shares
many
features
with
myalgic
encephalomyelitis/chronic
fatigue
(ME/CFS).
PCS
represents
a
major
health
issue
worldwide
because
it
severely
impacts
patients'
work
activities
and
their
quality
of
life.
In
the
absence
treatment
for
both
conditions
given
beneficial
effect
pacing
strategies
in
ME/CFS,
we
conducted
this
study
to
assess
effectiveness
patients.We
retrospectively
included
patients
meeting
World
Health
Organization
definition
who
attended
Internal
Medicine
Department
Angers
University
Hospital,
France
between
June
2020
2022,
were
followed
up
until
December
2022.
Pacing
systematically
proposed
all
patients.
Their
medical
records
reviewed
data
related
baseline
follow-up
assessments
collected.
This
epidemiological
characteristics,
COVID-19
symptoms
associated
conditions,
features,
perceived
status,
employment
activity,
degree
adherence
assessed
by
engagement
subscale
(EPS).
Recovery
was
defined
as
ability
return
work,
improvement
regarded
reduction
number
severity
symptoms.A
total
86
followed-up
median
time
10
[6-13]
months.
rates
33.7%
23.3%,
respectively.
The
EPS
score
only
variable
significantly
recovery
on
multivariate
analysis
(OR
40.43
[95%
CI
6.22-262.6],
p
<
0.001).
Patients
better
adhered
(high
scores)
experienced
higher
(60-33.3%
respectively)
than
those
low
(5.5-5.5%
respectively),
or
moderate
(4.3-17.4%
scores.Our
findings
demonstrated
that
is
effective
management
PCS,
high
levels
are
outcomes.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: June 7, 2023
Abstract
The
coronavirus
disease
2019
(COVID-19)
caused
by
SARS-CoV-2
infection
has
become
a
global
pandemic
due
to
the
high
viral
transmissibility
and
pathogenesis,
bringing
enormous
burden
our
society.
Most
patients
infected
are
asymptomatic
or
have
mild
symptoms.
Although
only
small
proportion
of
progressed
severe
COVID-19
with
symptoms
including
acute
respiratory
distress
syndrome
(ARDS),
disseminated
coagulopathy,
cardiovascular
disorders,
is
accompanied
mortality
rates
near
7
million
deaths.
Nowadays,
effective
therapeutic
patterns
for
still
lacking.
It
been
extensively
reported
that
host
metabolism
plays
essential
roles
in
various
physiological
processes
during
virus
infection.
Many
viruses
manipulate
avoid
immunity,
facilitate
their
own
replication,
initiate
pathological
response.
Targeting
interaction
between
holds
promise
developing
strategies.
In
this
review,
we
summarize
discuss
recent
studies
dedicated
uncovering
role
life
cycle
aspects
entry,
assembly,
pathogenesis
an
emphasis
on
glucose
lipid
metabolism.
Microbiota
long
also
discussed.
Ultimately,
recapitulate
metabolism-modulating
drugs
repurposed
statins,
ASM
inhibitors,
NSAIDs,
Montelukast,
omega-3
fatty
acids,
2-DG,
metformin.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(13), P. 10458 - 10458
Published: June 21, 2023
Long
COVID
(LC)
encompasses
a
constellation
of
long-term
symptoms
experienced
by
at
least
10%
people
after
the
initial
SARS-CoV-2
infection,
and
so
far
it
has
affected
about
65
million
people.
The
etiology
LC
remains
unclear;
however,
many
pathophysiological
pathways
may
be
involved,
including
viral
persistence;
chronic,
low-grade
inflammatory
response;
immune
dysregulation
defective
reactivation
latent
viruses;
autoimmunity;
persistent
endothelial
dysfunction
coagulopathy;
gut
dysbiosis;
hormonal
metabolic
dysregulation;
mitochondrial
dysfunction;
autonomic
nervous
system
dysfunction.
There
are
no
specific
tests
for
diagnosis
LC,
clinical
features
laboratory
findings
biomarkers
not
specifically
relate
to
LC.
Therefore,
is
paramount
importance
develop
validate
that
can
employed
prediction,
prognosis
its
therapeutic
response,
although
this
effort
hampered
challenges
pertaining
non-specific
nature
majority
manifestations
in
spectrum,
small
sample
sizes
relevant
studies
other
methodological
issues.
Promising
candidate
found
some
patients
markers
systemic
inflammation,
acute
phase
proteins,
cytokines
chemokines;
reflecting
persistence,
herpesviruses
endotheliopathy,
coagulation
fibrinolysis;
microbiota
alterations;
diverse
proteins
metabolites;
biomarkers;
cerebrospinal
fluid
biomarkers.
At
present,
there
only
two
reviews
summarizing
they
do
cover
entire
umbrella
current
biomarkers,
their
link
etiopathogenetic
mechanisms
or
diagnostic
work-up
comprehensive
manner.
Herein,
we
aim
appraise
synopsize
available
evidence
on
typical
classification
based
pathogenetic
main
symptomatology
frame
epidemiological
aspects
syndrome
furthermore
assess
limitations
as
well
potential
implications
interventions.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(8), P. 7445 - 7445
Published: April 18, 2023
In
addition
to
the
acute
symptoms
after
infection,
patients
and
society
are
also
being
challenged
by
long-term
effects
of
COVID-19,
known
as
long
COVID.
Oxidative
stress,
a
pivotal
point
in
pathophysiology
could
potentially
be
involved
development
post-COVID
syndrome.
The
aim
present
study
was
evaluate
relationship
between
changes
oxidative
status
persistence
long-COVID
workers
with
previous
mild
COVID-19
infection.
A
cross-sectional
conducted
among
127
employees
an
Italian
university
(80
47
healthy
subjects).
TBARS
assay
used
detect
malondialdehyde
serum
levels
(MDA),
while
total
hydroperoxide
(TH)
production
measured
d-ROMs
kit.
significant
difference
mean
MDA
values
found
previously
infected
subjects
controls
(4.9
µm
vs.
2.8
µm,
respectively).
Receiver–operating
characteristic
(ROC)
curves
showed
high
specificity
good
sensibility
(78.7%
67.5%,
respectively)
for
levels.
random
forest
classifier
identified
hematocrit
value,
levels,
IgG
titer
against
SARS-CoV-2
features
highest
predictive
value
distinguishing
34
from
46
asymptomatic
subjects.
damage
persists
suggesting
possible
role
stress
mediators
pathogenesis